Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Hormone therapy and different ovarian cancers: a national cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Effect estimates in randomized trials and observational studies: comparing apples with apples

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Age at Menarche and Risk of Multiple Sclerosis: A Prospective Cohort Study Based on the Danish National Birth Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pregnancy Loss and Cancer Risk: A Nationwide Observational Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for surgical intervention of early medical abortion

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Tidlig graviditet og abort - TiGrAb. Årsrapport 2018: RKKP 2019

    Research output: Book/ReportReportCommunication

  5. Ecological study on the use of hormonal contraception, abortions and births among teenagers in the Nordic countries

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Postmenopausal hormone therapy use increases the risk of ovarian cancer. In the present study, the authors examined the risks of different histologic types of ovarian cancer associated with hormone therapy. Using Danish national registers, the authors identified 909,946 women who were followed from 1995-2005. The women were 50-79 years of age and had no prior hormone-sensitive cancers or bilateral oophorectomy. Hormone therapy prescription data were obtained from the National Register of Medicinal Product Statistics. The National Cancer and Pathology Register provided data on ovarian cancers, including information about tumor histology. The authors performed Poisson regression analyses that included hormone exposures and confounders as time-dependent covariates. In an average of 8.0 years of follow up, 2,681 cases of epithelial ovarian cancer were detected. Compared with never users, women taking unopposed oral estrogen therapy had increased risks of both serous tumors (incidence rate ratio (IRR) = 1.7, 95% confidence interval: 1.4, 2.2) and endometrioid tumors (IRR = 1.5, 95% confidence interval: 1.0, 2.4) but decreased risk of mucinous tumors (IRR = 0.3, 95% confidence interval: 0.1, 0.8). Similar increased risks of serous and endometrioid tumors were found with estrogen/progestin therapy, whereas no association was found with mucinous tumors. Consistent with results from recent cohort studies, the authors found that ovarian cancer risk varied according to tumor histology. The types of ovarian tumors should be given attention in future studies.
Original languageEnglish
JournalAmerican Journal of Epidemiology
Volume175
Issue number12
Pages (from-to)1234-42
Number of pages9
ISSN0002-9262
DOIs
Publication statusPublished - 2012

ID: 34922259